RXRX logo

RXRX CAPEX

annual CAPEX:

$17.05M+$4.49M(+35.80%)
December 31, 2024

Summary

  • As of today (September 18, 2025), RXRX annual capital expenditures is $17.05 million, with the most recent change of +$4.49 million (+35.80%) on December 31, 2024.
  • During the last 3 years, RXRX annual CAPEX has fallen by -$22.75 million (-57.17%).
  • RXRX annual CAPEX is now -57.17% below its all-time high of $39.80 million, reached on December 31, 2021.

Performance

RXRX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXcash flow metrics

quarterly CAPEX:

$5.31M+$3.48M(+189.74%)
June 30, 2025

Summary

  • As of today (September 18, 2025), RXRX quarterly capital expenditures is $5.31 million, with the most recent change of +$3.48 million (+189.74%) on June 30, 2025.
  • Over the past year, RXRX quarterly CAPEX has increased by +$1.13 million (+26.92%).
  • RXRX quarterly CAPEX is now -72.66% below its all-time high of $19.42 million, reached on March 31, 2021.

Performance

RXRX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXcash flow metrics

TTM CAPEX:

$13.35M+$1.13M(+9.21%)
June 30, 2025

Summary

  • As of today (September 18, 2025), RXRX TTM capital expenditures is $13.35 million, with the most recent change of +$1.13 million (+9.21%) on June 30, 2025.
  • Over the past year, RXRX TTM CAPEX has dropped by -$729.00 thousand (-5.18%).
  • RXRX TTM CAPEX is now -66.46% below its all-time high of $39.80 million, reached on December 31, 2021.

Performance

RXRX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXcash flow metrics

RXRX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.8%+26.9%-5.2%
3 y3 years-57.2%-67.8%-61.8%
5 y5 years+335.9%+737.2%+912.9%

RXRX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.2%+35.8%-67.8%+541.8%-65.2%+9.2%
5 y5-year-57.2%+335.9%-72.7%+737.2%-66.5%+912.9%
alltimeall time-57.2%+335.9%-72.7%+737.2%-66.5%+1851.8%

RXRX CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$5.31M(+189.7%)
$13.35M(+9.2%)
Mar 2025
-
$1.83M(+11.2%)
$12.22M(-28.3%)
Dec 2024
$17.05M(+35.8%)
$1.65M(-63.9%)
$17.05M(-4.3%)
Sep 2024
-
$4.56M(+9.1%)
$17.81M(+26.5%)
Jun 2024
-
$4.18M(-37.1%)
$14.08M(+1.5%)
Mar 2024
-
$6.65M(+175.3%)
$13.87M(+10.5%)
Dec 2023
$12.55M(-66.4%)
$2.42M(+192.3%)
$12.55M(-30.7%)
Sep 2023
-
$827.00K(-79.2%)
$18.11M(-29.9%)
Jun 2023
-
$3.97M(-25.7%)
$25.85M(-32.6%)
Mar 2023
-
$5.34M(-33.1%)
$38.36M(+2.7%)
Dec 2022
$37.36M
$7.98M(-6.8%)
$37.36M(+10.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
$8.56M(-48.0%)
$33.84M(-3.3%)
Jun 2022
-
$16.48M(+279.4%)
$34.99M(+41.5%)
Mar 2022
-
$4.34M(-2.7%)
$24.72M(-37.9%)
Dec 2021
$39.80M(+490.9%)
$4.46M(-54.0%)
$39.80M(+12.6%)
Sep 2021
-
$9.71M(+56.2%)
$35.33M(+33.6%)
Jun 2021
-
$6.21M(-68.0%)
$26.45M(+26.7%)
Mar 2021
-
$19.42M(+2250.6%)
$20.88M(+873.7%)
Dec 2020
$6.74M(+72.3%)
-
-
Sep 2020
-
$826.00K(+30.3%)
$2.14M(+62.7%)
Jun 2020
-
$634.00K(-7.3%)
$1.32M(+92.7%)
Mar 2020
-
$684.00K
$684.00K
Dec 2019
$3.91M
-
-

FAQ

  • What is Recursion Pharmaceuticals, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. annual CAPEX year-on-year change?
  • What is Recursion Pharmaceuticals, Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
  • What is Recursion Pharmaceuticals, Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. TTM CAPEX year-on-year change?

What is Recursion Pharmaceuticals, Inc. annual capital expenditures?

The current annual CAPEX of RXRX is $17.05M

What is the all time high annual CAPEX for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high annual capital expenditures is $39.80M

What is Recursion Pharmaceuticals, Inc. annual CAPEX year-on-year change?

Over the past year, RXRX annual capital expenditures has changed by +$4.49M (+35.80%)

What is Recursion Pharmaceuticals, Inc. quarterly capital expenditures?

The current quarterly CAPEX of RXRX is $5.31M

What is the all time high quarterly CAPEX for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $19.42M

What is Recursion Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?

Over the past year, RXRX quarterly capital expenditures has changed by +$1.13M (+26.92%)

What is Recursion Pharmaceuticals, Inc. TTM capital expenditures?

The current TTM CAPEX of RXRX is $13.35M

What is the all time high TTM CAPEX for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high TTM capital expenditures is $39.80M

What is Recursion Pharmaceuticals, Inc. TTM CAPEX year-on-year change?

Over the past year, RXRX TTM capital expenditures has changed by -$729.00K (-5.18%)
On this page